| scholarly article | Q13442814 |
| P2093 | author name string | Joanne E Nash | |
| Ruth Warre | |||
| Sherri L Thiele | |||
| P2860 | cites work | Parkinson's disease: mechanisms and models | Q29547424 |
| D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
| A gene expression atlas of the central nervous system based on bacterial artificial chromosomes | Q29617753 | ||
| Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
| Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice | Q33215982 | ||
| Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease | Q33596638 | ||
| Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. | Q33817654 | ||
| Behavioral phenotyping of the MPTP mouse model of Parkinson's disease | Q34420632 | ||
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates. | Q35969693 | ||
| Novel approaches to the symptomatic treatment of parkinsonian syndromes: alternatives and adjuncts to dopamine-replacement | Q41573347 | ||
| Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat. | Q42000019 | ||
| A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function | Q42463405 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Characterization of a rodent model in which to investigate the molecular and cellular mechanisms underlying the pathophysiology of L-dopa-induced dyskinesia | Q42539453 | ||
| Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons | Q42682549 | ||
| MPTP-induced models of Parkinson's disease in mice and non-human primates | Q42726539 | ||
| Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle | Q43538536 | ||
| Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients | Q48087749 | ||
| On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus | Q48194684 | ||
| Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway | Q48405151 | ||
| Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study | Q48666967 | ||
| Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. | Q48876521 | ||
| Metabolism of tyramine-3H and octopamine-3H by rat brain | Q49045775 | ||
| Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling | Q49130167 | ||
| Generation of a model of L-DOPA-induced dyskinesia in two different mouse strains. | Q50526050 | ||
| On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat. | Q54047216 | ||
| Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms | Q69754343 | ||
| [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions | Q69924137 | ||
| Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity | Q71525171 | ||
| CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury | Q73503153 | ||
| P433 | issue | 60 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P577 | publication date | 2012-02-14 | |
| P1433 | published in | Journal of Visualized Experiments | Q954500 |
| P1476 | title | Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease |
| Q48196426 | 6-OHDA-Lesioned Adult Zebrafish as a Useful Parkinson's Disease Model for Dopaminergic Neuroregeneration |
| Q47581099 | Alpha Lipoamide Ameliorates Motor Deficits and Mitochondrial Dynamics in the Parkinson's Disease Model Induced by 6-Hydroxydopamine |
| Q39107780 | Axial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum. |
| Q33790301 | Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models |
| Q64265119 | Disruption of Cortical Dopaminergic Modulation Impairs Preparatory Activity and Delays Licking Initiation |
| Q89452010 | Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum |
| Q91276743 | Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli |
| Q89979814 | Enhanced Bidirectional Connectivity of the Subthalamo-pallidal Pathway in 6-OHDA-mouse Model of Parkinson's Disease Revealed by Probabilistic Tractography of Diffusion-weighted MRI at 9.4T |
| Q26772843 | Evaluation of Models of Parkinson's Disease |
| Q47441179 | Evidence for cross-hemispheric preconditioning in experimental Parkinson's disease. |
| Q40719044 | Hematopoietic cytokines as therapeutic players in early stages Parkinson's disease. |
| Q92564156 | High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment |
| Q64768761 | In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study |
| Q38714411 | Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway |
| Q35049928 | Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse. |
| Q40625594 | Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease |
| Q61445625 | Partial depletion of dopaminergic neurons in the substantia nigra impairs olfaction and alters neural activity in the olfactory bulb |
| Q90180957 | Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons |
| Q47159261 | Phosphorylation of LAMP2A by p38 MAPK couples ER stress to chaperone-mediated autophagy |
| Q57035137 | Reduction of HIP2 expression causes motor function impairment and increased vulnerability to dopaminergic degeneration in Parkinson's disease models |
| Q41584434 | Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models |
| Q39018573 | Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation |
| Q47146624 | The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage |
| Q64242354 | Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on L-Dopa induced dyskinesia |
Search more.